Beyond The Age Limit: A Comparative Study (
These findings demonstrate important differences in disease presentation and surgical management between age groups in Turkey, where breast cancer screening ends at age 69. The absence of screening detection in elderly patients, combined with their advanced disease presentation, highlights the need for further investigation with larger, multicenter cohorts to evaluate optimal screening strategies for women beyond age 69.
Authors
- Yusuf Emre Altundal (ORCID: https://orcid.org/0000-0002-1196-0053)
- Süleyman Büyükaşık (ORCID: https://orcid.org/0000-0001-5536-4395)
- Selin Kapan (ORCID: https://orcid.org/0000-0001-9339-4894)
- Burak Kankaya (ORCID: https://orcid.org/0000-0002-5451-7166)
- Mustafa Ozgul (ORCID: https://orcid.org/0009-0002-0462-311X)
Institutions
- Istanbul Aydın University (TR)
- University of California, Irvine (US)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/bctt.s555684
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00